Healthcare comparison

JNJ vs ABBV Dividend Stock Comparison 2026

Compare Johnson & Johnson and AbbVie Inc. by dividend yield, payout safety, dividend growth, quality score, and Geraldine Weiss valuation signal across pharma dividend stocks.

ABBV (3.12%)

Higher yield

JNJ (47/100)

Better quality

ABBV (6.8%)

Faster 5Y growth

Tie / neutral

Weiss signal edge

Compare Dividend Stocks

Compare yield, Weiss signal, quality score, and dividend growth side by side.

JNJ
Johnson & Johnson
Overvalued
Healthcare
King
ABBV
AbbVie Inc.
Overvalued
Healthcare
King
MetricJNJABBV
Price$234.34$215.70
Annual Dividend$5.20$6.74
Current Yield2.22%3.12%
Weiss Signal
Overvalued
Overvalued
Quality Score47/10045/100
Dividend Streak64 yrs54 yrs
CAGR 5Y5.2%6.8%
CAGR 10Y5.7%12.5%
Payout Ratio60%
FCF Payout103%59%
Undervalued Price$152.32$132.75
Overvalued Price$191.09$220.40
Median Yield (hist.)3.28%4.76%
Read our in-depth JNJ vs ABBV analysis →

How to read this comparison

Start with the Weiss signal to see whether either stock is historically cheap relative to its own dividend yield history. Then compare quality score, payout ratio, and dividend growth to avoid choosing a stock only because the current yield is higher.

A higher yield can mean better income value, but it can also signal slower growth or higher dividend risk. The strongest dividend comparison winner usually combines an attractive Weiss signal, a manageable payout ratio, positive dividend growth, and a quality score that is stronger than the peer.

Full charts on TradingView:JNJABBV